United States Atrial Fibrillation Market Surges with Breakthrough Therapies and Rising Patient Demand 2025 | Top key players - AdvaCare Pharma, Sanofi, Pfizer Inc.

Market Size and Growth:

The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033.

The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Atrial Fibrillation market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/atrial-fibrillation-market?sz

The Atrial Fibrillation Market refers to the global industry focused on diagnosing, treating, and managing atrial fibrillation, a common heart rhythm disorder. It encompasses pharmaceuticals, medical devices, catheter ablation systems, monitoring technologies, and healthcare services. Market growth is driven by rising cardiovascular disease prevalence, aging populations, technological advancements, and increasing demand for minimally invasive treatment options worldwide.

Recent Key Developments of United States (U.S):

Pulsed Field Ablation (PFA) Approvals: The U.S. FDA granted approval to Kardium Inc.'s Globe Pulsed Field System in September 2025 for treating atrial fibrillation, allowing it to enter the competitive PFA market alongside other major players.

Expansion of PFA System Labeling: In July 2025, Boston Scientific received FDA approval to expand the labeling of its FARAPULSE PFA System to treat persistent atrial fibrillation, a more advanced form of the condition.

Clinical Trial for New PFA System: Pulse Biosciences received FDA Investigational Device Exemption (IDE) approval in September 2025 to begin the NANOCLAMP AF trial for its Nanosecond Pulsed Field Ablation (nsPFA) Cardiac Surgery System. This is the first time this technology is being tested in the cardiac surgical field.

Continued Clinical Advancements in PFA: New clinical data from the Omny-IRE study, presented in April 2025, demonstrated the safety and efficacy of Johnson & Johnson MedTech's OMNYPULSETM Platform, further advancing the understanding of PFA technology.

Novel Drug Development: The Atrial Fibrillation drug pipeline continues to be active with companies like HUYA Bioscience and Milestone Pharmaceuticals advancing their therapies. HBI-3000 and Etripamil are examples of drugs in late-stage clinical trials that aim to offer new treatment options for patients.

Key Players:

AdvaCare Pharma
Sanofi
Pfizer Inc.
Teva Pharmaceuticals USA, Inc.
Glenmark Pharmaceuticals Inc.
GSK plc.
Boehringer Ingelheim Pharmaceuticals, Inc.
Bayer AG
DAIICHI SANKYO COMPANY, LIMITED.
AstraZeneca
Johnson & Johnson
Boston Scientific Corporation
Medtronic
Abbott.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=atrial-fibrillation-market

Market Segmentation:

By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Others.

By End-User: Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/atrial-fibrillation-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Atrial Fibrillation market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Atrial Fibrillation Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Atrial Fibrillation market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Atrial Fibrillation Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Atrial Fibrillation Market in 2025?
◆ What is the projected growth rate of the Atrial Fibrillation Market through 2033?
◆ Who are the key players in the Atrial Fibrillation Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.